Brief: Foghorn Therapeutics Q1 EPS USD -0.73
08/05/2023 12:23
May 8 (Reuters) - Foghorn Therapeutics Q1 collaboration revenue USD 5.309 million. * Q1 EPS USD -0.73 * Q1 net income USD -30.488 million
FHTX — Foghorn Therapeutics News Story
0.000.00%
Last trade - 00:00- $118.77m
- -$48.81m
- $30.91m